Recent Posts in ‘Featured Companies’
Cardium’s (CXM) MedPodium Nutra-Apps® Expands Distribution
Cardium Therapeutics (NYSE Amex: CXM), a health sciences and regenerative medicine company focused on the acquisition of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs and definable pathways to commercialization, offering product lines similar to companies such as Nutraceutical International Corp (NASDAQ: NUTR) and Schiff Nutrition
Stem Cell Headlines Highlight Importance of FDA Decisions to Athersys (ATHX) and Others
Companies mentioned in this article include Neuralstem Inc. (AMEX: CUR), StemCells Inc. (NASDAQ: STEM), and Athersys Inc. (NASDAQ: ATHX). There’s no arguing that stem cells therapies have been a hot button topic of controversy for years. The days are few and far between where there isn’t something in the media that highlights some aspect of
Pressure BioSciences (PBIO): Reading Between the Lines
Pressure BioSciences, Inc. (OTCQB: PBIO), a developer of proprietary lab instrumentation and associated consumables based on its game changing Pressure Cycling Technology (PCT), providing equipment to companies like Thermo Fisher Scientific (NYSE: TMO) and Amgen Inc. (NASDAQ: AMGN), recently announced a very attractive equity financing, when reading between the lines. Above-Market Pricing with Great Terms
Pressure BioSciences (PBIO) Secures $500K Investment on Very Attractive Terms
Pressure BioSciences Inc. (OTCQB: PBIO), a developer of proprietary laboratory instrumentation and associated consumables based on its game-changing Pressure Cycling Technology (PCT), competing against other companies in the sample preparation technology sector, like Qiagen NV (NASDAQ: QGEN) and Becton, Dickenson and Co. (NYSE: BDX), just announced that they had secured a $500,000 preferred stock investment
Cardium (CXM) Initiates Generx(R) Phase 3 Clinical Registration Study
Cardium Therapeutics (NYSE Amex: CXM), a health sciences and regenerative company focused on the acquisition of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs and definable pathways to commercialization, like companies such as Impax Laboratories Inc. (Nasdaq: IPXL) and Biogen Idec Inc. (Nasdaq: BIIB), recently announced
Pressure BioSciences (PBIO): How Much is It Really Worth?
Pressure BioSciences Inc. (NASDAQ: PBIO), a developer of proprietary lab instrumentation and associated consumables based on its game-changing Pressure Cycling Technology (PCT), providing equipment to companies like Thermo Fisher Scientific (NYSE: TMO) and Amgen Inc. (NASDAQ: AMGN), appears to be significantly undervalued by the market. Significant Growth Potential Ahead Pressure BioSciences is preparing to commercialize
ALR Technologies (ALRT) Schedules Webcast to Discuss 510K Clearance & Product Launch
ALR Technologies Inc.(OTC.BB: ALRT.OB) (the “Company”), a healthcare technology company, is pleased to announce that it will be hosting an investor meeting after the market closes on Monday, March 19, 2012 at 4:30 PM EDT. The meeting will be conducted in a webinar format, including an investor presentation by Sidney S. Chan, Chairman and Chief Executive Officer
Pressure BioSciences (PBIO): A Game-Changing Technology Platform
Pressure BioSciences Inc. (NASDAQ: PBIO) is a developer of proprietary laboratory instrumentation and associated consumables based on its game-changing Pressure Cycling Technology (PCT), competing against other companies in the sample preparation technology sector, like Qiagen NV (NASDAQ: QGEN) and Becton, Dickenson and Co. (NYSE: BDX). Simplifying and Improving Sample Preparation Lab sample preparation is often
ImmunoCellular’s Licensing Agreement with University of Pennsylvania Next Step on Prosperity’s Path
Shepherding a biotechnology company down the regulatory pathway is full of value-driving milestones; some just generally not as widely acknowledged as others. Of course, the major accomplishments, such as moving from one clinical phase to the next, deservedly send share prices higher, but there are many other steps that more subtly signal corporation advancements and
ALR Technologies (ALRT): Penny Stock, Recent FDA Clearance, Enormous Potential
ALR Technologies Inc. (OTCBB: ALRT), an innovative medical device company, offers a unique software solution aimed at improving patient adherence to care plans in the diabetes industry working alongside companies like Abbott Laboratories (NYSE: ABT) and Bayer AG (PINK: BAYRY) that develop diabetes testing supplies. Meanwhile, diabetes is becoming a growing problem around the world.
Cardium (CXM) Inks First Marketing & Distribution Agreement for Excellagen(TM)
Cardium Therapeutics (Amex: CXM), a developer and acquirer of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, similar to companies like Impax Laboratories Inc. (Nasdaq: IPXL) and Biogen Idec Inc. (Nasdaq: BIIB), recently entered into first marketing and distribution agreement